Accelerating neuronal aging in in vitro model brain disorders: A focus on reactive oxygen species

Frontiers in Aging Neuroscience

Volumn 6, Issue OCT, 2014, Pages

  Campos, Priscila Britto ^a   Paulsen, Bruna S ^a   Rehen, Stevens K ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

Aged neurons; Alzheimer; Parkinson; Pluripotent stem cells; ROS; Schizophrenia

Indexed keywords

ADENOSINE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN NERVE CELL; CELL AGING; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DEGENERATIVE DISEASE; GENE MUTATION; HUMAN; IN VITRO STUDY; MICROENVIRONMENT; OXIDATIVE STRESS; PARKINSON DISEASE; PLURIPOTENT STEM CELL; REVIEW; SCHIZOPHRENIA;

EID: 84909578705     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00292     Document Type: Review

References (88)

1. Armstrong, L., Tilgner, K., Saretzki, G., Atkinson, S., Stojkovic, M., Moreno, R., et al. (2010). Human induced pluripotent stem cell lines show stress defense human embryonic stem cells. Stem Cells 28, 661-673. doi: 10.1002/stem.307
2. Badger, J. L., Cordero-llana, O., Hartfield, E. M., and Wade-martins, R. (2014). Parkinson's disease in a dish-Using stem cells as a molecular tool. Neuropharmacology 76, 88-96. doi: 10.1016/j.neuropharm.2013.08.035
3. Ballesteros, A., Summerfelt, A., Du, X., Jiang, P., Chiappelli, J., Tagamets, M., et al. (2013). Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin. Neurophysiol. 124, 2209-2215. doi: 10.1016/j.clinph.2013.05.021
4. Barnham, K. J., Masters, C. L., and Bush, A. I. (2004). Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214. doi: 10.1038/nrd1330
5. Bertram, L., and Tanzi, R. E. (2005). The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115, 1449-1457. doi: 10.1172/jci24761
6. Bezprozvanny, I., and Mattson, M. P. (2008). Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31, 454-463. doi: 10.1016/j.tins.2008.06.005
7. Bitanihirwe, B. K. Y., and Woo, T. W. (2011). Oxidative stress in schizophrenia: an integrated approach. Neurosci. Biobehav. Rev. 35, 878-893. doi: 10.1016/j.neubiorev.2010.10.008
8. Boison, D. (2008). Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 8, 2-7. doi: 10.1016/j.coph.2007.09.002
9. Botella-López, A., Burgaya, F., Gavín, R., García-Ayllón, M. S., Gómez-Tortosa, E., Peña-Casanova, J., et al. (2006). Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U S A 103, 5573-5578. doi: 10.1073/pnas.0601279103
10. Byers, B., Cord, B., Nguyen, H. N., Schül, B., Fenno, L., Lee, P. C., et al. (2011). SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate a-synuclein and are susceptible to oxidative stress. PLoS One 6:e26159. doi: 10.1371/journal.pone.0026159
11. Calabrese, V., Guagliano, E., Sapienza, M., Panebianco, M., Calafato, S., Puleo, E., et al. (2007). Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem. Res. 32, 757-773. doi: 10.1007/s11064-006-9203-y
12. Cannon, J. R., Tapias, V. M., Na, H. M., Honick, A. S., Drolet, R. E., and Greenamyre, J. T. (2009). A high reproducoble rotenone model of Parkinson's disease. Neurobiol. Dis. 34, 279-290. doi: 10.1016/j.nbd.2009.01.016
13. Cardno, A. G., and Gottesman, I. I. (2000). Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97, 12-17. doi: 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U
14. Castillo, C. A., Albasanz, J. L., León, D., Jordán, J., Pallàs, M., Camins, A., et al. (2009). Age-related expression of adenosine receptors in brain from the senescence-accelerated mouse. Exp. Gerontol. 44, 453-461. doi: 10.1016/j.exger.2009.04.006
15. Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d'Hellencourt, C., and Ravanan, P. (2014). A molecular web: endoplasmic reticulum stress, inflammation and oxidative stress. Front. Cell. Neurosci. 8:213. doi: 10.3389/fncel.2014.00213
16. Circu, M. L., and Aw, T. Y. (2010). Reactive oxygen species, cellular redox systems and apoptosis. Free Radic. Biol. Med. 48, 749-762. doi: 10.1016/j.freeradbiomed.2009.12.022
17. Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., et al. (2012). Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci. Transl. Med. 4:141ra90. doi: 10.1126/scitranslmed.3003985
18. Currais, A., and Maher, P. (2013). Functional consequences of age-dependent changes in glutathione status in the brain. Antioxid. Redox Signal. 19, 813-822. doi: 10.1089/ars.2012.4996
19. Dias, V., Junn, E., and Mouradian, M. M. (2013). The role of oxidative stress in Parkinson's disease. J. Parkinsons. Dis. 3, 461-491. doi: 10.3233/JPD-130230
20. Dror, N., Klein, E., Karry, R., Sheinkman, A., Kirsh, Z., Mazor, M., et al. (2002). State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol. Psychiatry 7, 995-1001. doi: 10.1038/sj.mp.4001116
21. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., and Loguercio, C. (2007). Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 121, 2381-2386. doi: 10.1002/ijc.23192
22. Fernandez-Egea, E., Bernardo, M., Heaphy, C. M., Griffith, J. K., Parellada, E., Esmatjes, E., et al. (2009). Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr. Bull. 35, 437-442. doi: 10.1093/schbul/sbn169
23. Finkel, T., and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247. doi: 10.1038/35041687
24. Ghneim, H. K., Al-Saleh, S. S., Al-Shammary, F. J., and Kordee, Z. S. (2003). Changes in adenosine deaminase activity in ageing cultured human cells and the role of zinc. Cell Biochem. Funct. 21, 275-282. doi: 10.1002/cbf.1023
25. Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., et al. (2007). Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl. Acad. Sci. U S A 104, 16621-16626. doi: 10.1073/pnas.0706778104
26. Herz, J., and Chen, Y. (2006). Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 7, 850-859. doi: 10.1038/nrn2009
27. Hooper, C., Killick, R., and Lovestone, S. (2008). The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433-1439. doi: 10.1111/j.1471-4159.2007.05194.x
28. Hsieh, H.-L., and Yang, C.-M. (2013). Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res. Int. 2013:484613. doi: 10.1155/2013/484613
29. Hu, B.-Y., and Zhang, S.-C. (2009). Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 4, 1295-1304. doi: 10.1038/nprot.2009.127
30. Insel, T. R. (2010). Rethinking schizophrenia. Nature 468, 187-193. doi: 10.1038/nature09552
31. Jacobsen, J. P. R., Rodriguiz, R. M., Mørk, A., and Wetsel, W. C. (2005). Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia? Neuroscience 132, 1055-1072. doi: 10.1016/j.neuroscience.2005.01.059
32. Jeste, D. V., Wolkowitz, O. M., and Palmer, B. W. (2011). Divergent trajectories of physical, cognitive and psychosocial aging in schizophrenia. Schizophr. Bull. 37, 451-455. doi: 10.1093/schbul/sbr026
33. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., and Selkoe, D. J. (2011). Soluble amyloid ß -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U S A 108, 5819-5824. doi: 10.1073/pnas.1017033108
34. Jung, H.-J., Coffinier, C., Choe, Y., Beigneux, A. P., Davies, B. S. J., Yang, S. H., et al. (2012). Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc. Natl. Acad. Sci. U S A 109, E423-E431. doi: 10.1073/pnas.1111780109
35. Katsimpardi, L., Litterman, N. K., Schein, P. A., Miller, C. M., Loffredo, F. S., Wojtkiewicz, G. R., et al. (2014). Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 344, 630-634. doi: 10.1126/science.1251141
36. Keeney, P. M., Xie, J., Capaldi, R. A., and Bennett, J. P. Jr. (2006). Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26, 5256-5264. doi: 10.1523/jneurosci.0984-06.2006
37. Kelly, R. D. W., Sumer, H., McKenzie, M., Facucho-oliveira, J., Trounce, I. A., Verma, P. J., et al. (2013). The effects of nuclear reprogramming on mitochondrial DNA replication. Stem Cell Rev. 9, 1-15. doi: 10.1007/s12015-011-9318-7
38. Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E., and Bowie, C. R. (2008). Is schizophrenia a syndrome of accelerated aging? Schizophr. Bull. 34, 1024-1032. doi: 10.1093/schbul/sbm140
39. Kochunov, P., Glahn, D. C., Rowland, L. M., Olvera, R. L., Winkler, A., Yang, Y., et al. (2013). Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol. Psychiatry 73, 482-491. doi: 10.1016/j.biopsych.2012.10.002
40. Koutsouleris, N., Davatzikos, C., Borgwardt, S., Gaser, C., Bottlender, R., Frodl, T., et al. (2014). Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr. Bull. 40, 1140-1153. doi: 10.1093/schbul/sbt142
41. Kulak, A., Steullet, P., Cabungcal, J.-H., Werge, T., Ingason, A., Cuenod, M., et al. (2013). Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxid. Redox Signal. 18, 1428-1443. doi: 10.1089/ars.2012.4858
42. Le Belle, J. E., Orozco, N. M., Paucar, A. A., Saxe, J. P., Mottahedeh, J., Pyle, A. D., et al. (2011). Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 8, 59-71. doi: 10.1016/j.stem.2010.11.028
43. Liochev, S. I. (2013). Reactive oxygen species and the free radical theory of aging. Free Radic. Biol. Med. 60, 1-4. doi: 10.1016/j.freeradbiomed.2013.02.011
44. Liu, A. Y., Chang, Z. F., and Chen, K. Y. (1986). Increased level of cAMP-dependent protein kinase in aging human lung fibroblasts. J. Cell. Physiol. 128, 149-154. doi: 10.1002/jcp.1041280203
45. Liu, H., Wang, H., Shenvi, S., Hagen, T. M., and Liu, R.-M. (2004). Glutathione metabolism during aging and in Alzheimer disease. Ann. N Y Acad. Sci. 1019, 346-349. doi: 10.1196/annals.1297.059
46. Liu, B., and Zhou, Z. (2008). Lamin A/C, laminopathies and premature ageing. Histol. Histopathol. 23, 747-763.
47. Mackiewicz, M., Nikonova, E. V., Zimmermann, J. E., Romer, M. A., Cater, J., Galante, R. J., et al. (2006). Age-related changes in adenosine metabolic enzymes in sleep/wake regulatory areas of the brain. Neurobiol. Aging 27, 351-360. doi: 10.1016/j.neurobiolaging.2005.01.015
48. Mariani, J., Vittoria, M. V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A. M., et al. (2012). Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. U S A 109, 12770-12775. doi: 10.1073/pnas.1202944109
49. Marion, R. M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., et al. (2009). Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154. doi: 10.1016/j.stem.2008.12.010
50. Melov, S., Adlard, P. A., Morten, K., Johnson, F., Golden, T. R., Hinerfeld, D., et al. (2007). Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2:e536. doi: 10.1371/journal.pone.0000536
51. Micó, J. A., Rojas-Corrales, M. O., Gibert-Rahola, J., Parellada, M., Moreno, D., Fraguas, D., et al. (2011). Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry 11:26. doi: 10.1186/1471-244X-11-26
52. Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., et al. (2013). Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691-705. doi: 10.1016/j.stem.2013.11.006
53. Miyoshi, N., Oubrahim, H., Chock, P. B., and Stadtman, E. R. (2006). Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis. Proc. Natl. Acad. Sci. U S A 103, 1727-1731. doi: 10.1073/pnas.0510346103
54. Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., et al. (2006). Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452. doi: 10.1038/nature05091
55. Mori, T., Ohnishi, T., Hashimoto, R., Nemoto, K., Moriguchi, Y., Noguchi, H., et al. (2007). Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res. 154, 133-145. doi: 10.1016/j.pscychresns.2006.09.004
56. Murakami, K., Murata, N., Noda, Y., Tahara, S., Kaneko, T., Kinoshita, N., et al. (2011). SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid ß protein oligomerization and memory loss in mouse model of Alzheimer disease. J. Biol. Chem. 286, 44557-44568. doi: 10.1074/jbc. M111.279208
57. Murray, R. M., and Lewis, S. W. (1987). Is schizophrenia a neurodevelopmental disorder? Br. Med. J. 295, 681-682. doi: 10.1136/bmj.295.6608.1278-c
58. Nayernia, Z., Jaquet, V., and Krause, K.-H. (2014). New insights on NOX enzymes in the central nervous system. Antioxid. Redox Signal. 20, 2815-2837. doi: 10.1089/ars.2013.5703
59. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., et al. (2011). LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267-280. doi: 10.1016/j.stem.2011.01.013
60. Nicholas, C. R., Chen, J., Tang, Y., Southwell, D. G., Vogt, D., Arnold, C. M., et al. (2014). Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573-586. doi: 10.1016/j.stem.2013.04.005
61. Nissan, X., Blondel, S., Navarro, C., Maury, Y., Denis, C., Girard, M., et al. (2012). Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep. 2, 1-9. doi: 10.1016/j.celrep.2012.05.015
62. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E., et al. (2001). Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
63. Parish, S. T., Kim, S., Sekhon, R. K., Wu, J. E., and Kawakatsu, Y. (2013). Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 lymphocytes. J. Immunol. 184, 2847-2854. doi: 10.4049/jimmunol.0903647
64. Paulsen, B. D. S., de Moraes Maciel, R., Galina, A., Souza da Silveira, M., dos Santos Souza, C., Drummond, H., et al. (2012). Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant. 21, 1547-1559. doi: 10.3727/096368911X600957
65. Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., and Buga, A.-M. (2013). ROS and brain diseases: the good, the bad and the ugly. Oxid. Med. Cell. Longev. 2013:963520. doi: 10.1155/2013/963520
66. Rafalski, V. A., and Brunet, A. (2011). Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 93, 182-203. doi: 10.1016/j.pneurobio.2010.10.007
67. Ragnauth, C. D., Warren, D. T., Liu, Y., McNair, R., Tajsic, T., Figg, N., et al. (2010). Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121, 2200-2210. doi: 10.1161/CIRCULATIONAHA.109.902056
68. Rodier, F., and Campisi, J. (2011). Four faces of cellular senescence. J. Cell Biol. 192, 547-556. doi: 10.1083/jcb.201009094
69. Ryder, J., Su, Y., and Ni, B. (2004). Akt/GSK3ß serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations. Cell. Signal. 16, 187-200. doi: 10.1016/j.cellsig.2003.07.004
70. Saetre, P., Emilsson, L., Axelsson, E., Kreuger, J., Lindholm, E., and Jazin, E. (2007). Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7:46. doi: 10.1186/1471-244X-7-46
71. Saha, K., and Jaenisch, R. (2009). Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584-595. doi: 10.1016/j.stem.2009.11.009
72. Shetty, A. K., Hattiangady, B., and Shetty, G. A. (2005). Stem/progenitor cell proliferation factors FGF-2, IGF-1 and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 51, 173-186. doi: 10.1002/glia.20187
73. Smith, E. D., Kudlow, B. A., Frock, R. L., and Kennedy, B. K. (2005). A-type nuclear lamins, progerias and other degenerative disorders. Mech. Ageing Dev. 126, 447-460. doi: 10.1016/j.mad.2004.10.006
74. Steullet, P., Neijt, H. C., Cuénod, M., and Do, K. Q. (2006). Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 137, 807-819. doi: 10.1016/j.neuroscience.2005.10.014
75. Stoll, E. A., Cheung, W., Mikheev, A. M., Sweet, I. R., Bielas, J. H., Zhang, J., et al. (2011). Aging neural progenitor cells have decreased mitochondrial content and lower oxidative metabolism. J. Biol. Chem. 286, 38592-38601. doi: 10.1074/jbc. M111.252171
76. Suhr, S. T., Chang, E. A., Tjong, J., Alcasid, N., Perkins, G. A., Goissis, M. D., et al. (2010). Mitochondrial rejuvenation after induced pluripotency. PLoS One 5:e14095. doi: 10.1371/journal.pone.0014095
77. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. doi: 10.1016/j.cell.2006.07.024
78. Tang, B., Chang, W., Lanigan, C. M., Dean, B., Sutcliffe, J. G., and Thomas, E. A. (2009). Normal human aging and early-stage schizophrenia share commom molecular profiles. Aging Cell 8, 339-342. doi: 10.1111/j.1474-9726.2009.00468.x
79. Uttara, B., Singh, A. V., Zamboni, P., and Mahajan, R. T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65-74. doi: 10.2174/157015909787602823
80. Villeda, S. A., Plambeck, K. E., Middeldorp, J., Castellano, J. M., Mosher, K. I., Luo, J., et al. (2014). Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20, 1-8. doi: 10.1038/nm.3569
81. Viteri, G., Chung, Y. W., and Stadtman, E. R. (2010). Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients. Mech. Ageing Dev. 131, 2-8. doi: 10.1016/j.mad.2009.11.006
82. Wyss-Coray, T. (2006). Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015. doi: 10.1038/nm1484
83. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., et al. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23, 781-790. doi: 10.1634/stemcells.2004-0365
84. Yang, Y., Bazhin, A. V., Werner, J., and Karakhanova, S. (2013a). Reactive oxygen species in the immune system. Int. Rev. Immunol. 32, 249-270. doi: 10.3109/08830185.2012.755176
85. Yang, D., Song, J., Wu, L., Ma, Y., Song, C., Dovat, S., et al. (2013b). Induction of senescence by adenosine suppressing the growth of lung cancer cells. Biochem. Biophys. Res. Commun. 440, 62-67. doi: 10.1016/j.bbrc.2013.09.030
86. Yin, F., Jiang, T., and Cadenas, E. (2013). Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling. Biochem. Soc. Trans. 41, 101-105. doi: 10.1042/BST20120260
87. Yoshikawa, K. (2000). Cell cycle regulators in neural stem cells and postmitotic neurons. Neurosci. Res. 37, 1-14. doi: 10.1016/S0168-0102(00)00101-2
88. Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785-798. doi: 10.1016/j.neuron.2013.05.029